Illinois Transplant Fund Experience: Is It a Pathway to Increased Transplant Access for Hispanic Patients With Kidney Failure?

• Published in: Kidney medicine 2024-01, Vol.6 (1), p.100742-100742, Article 100742
• Main Authors: Isgor, Zeynep, Johnson, Tricia, Cmunt, Kevin, Lange-Maia, Brittney S.
• Format: Article
• Language: English
• Subjects: End Stage Kidney Disease; Health Policy; Hispanic; Hispanic, Noncitizens; kidney disease; Kidney Disease, kidney failure; kidney failure; noncitizens; Racial/Ethnic Disparities; Transplant Waitlist, Private Insurance; Undocumented Residents, Transplant
• ISSN: 2590-0595; 2590-0595
• DOI: 10.1016/j.xkme.2023.100742

The Illinois Transplant Fund, established in 2015, provides private health insurance premium support for noncitizen patients with kidney failure in Illinois, and thus allows them to qualify for kidney transplants. Our objective was to describe trends in kidney transplant volumes over time to inform the development of a hypothesis regarding the impact of the Illinois Transplant Fund on kidney transplant volumes for adult Hispanic patients with kidney failure in Illinois, especially noncitizen patients. Retrospective study We utilized data on the annual number of kidney transplants and kidney failure prevalence aggregated to the national and state levels from the Organ Procurement and Transplantation Network and United States Renal Data System, respectively. Annual number of transplants as a percentage of prevalent kidney failure cases among adults was examined over time from 2010 to 2020 by race/ethnicity for all payer and private insurance-paid transplants and annual number of transplants by citizenship status (for Hispanic patients only) for the United States (US), Illinois, and six selected US states. Descriptive study From pre- to post- Illinois Transplant Fund, the average annual number of transplants as a percentage of average annual prevalent kidney failure cases for Hispanic adults increased by 4% in Illinois while the same figure increased by 33% for privately insured transplants. The observations reported in this paper cannot be interpreted as evidence for the program’s impact. Observed trends suggest plausibility of developing a hypothesis that Illinois Transplant Fund's introduction may have contributed to improvement in kidney transplantation access for Hispanic patients in Illinois, especially noncitizens, but cannot constitute evidence in support or against this hypothesis. Future research should test whether the Illinois Transplant Fund improved access to kidney transplants for noncitizens with kidney failure.